Tempus AI Debt to Equity Ratio 2023-2025 | TEM
Current and historical debt to equity ratio values for Tempus AI (TEM) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Tempus AI debt/equity for the three months ending March 31, 2025 was 2.45.
| Tempus AI Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $1.22B | $0.33B | 3.73 |
| 2024-12-31 | $0.87B | $0.06B | 15.44 |
| 2024-09-30 | $0.92B | $0.05B | 17.09 |
| 2024-06-30 | $0.77B | $0.10B | 7.80 |
| 2024-03-31 | $1.94B | $-1.47B | -1.32 |
| 2023-12-31 | $1.95B | $-1.38B | -1.41 |
| 2023-09-30 | $0.00B | $0.00B | 0.00 |
| 2023-06-30 | $0.00B | $0.00B | 0.00 |
| 2023-03-31 | $0.00B | $0.00B | 0.00 |
| 2022-12-31 | $1.76B | $-1.13B | -1.56 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $11.334B | $0.693B |
| Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.674B | 58.11 |
| Doximity (DOCS) | United States | $11.302B | 52.32 |
| Hims & Hers Health (HIMS) | United States | $9.269B | 96.30 |
| IRhythm Technologies (IRTC) | United States | $4.836B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.893B | 60.83 |
| Hinge Health (HNGE) | United States | $3.474B | 0.00 |
| Privia Health (PRVA) | United States | $2.652B | 181.25 |
| Enovis (ENOV) | United States | $1.835B | 10.23 |
| Phreesia (PHR) | United States | $1.643B | 0.00 |
| Schrodinger (SDGR) | United States | $1.509B | 0.00 |
| 10x Genomics (TXG) | United States | $1.436B | 0.00 |
| Azenta (AZTA) | United States | $1.397B | 64.92 |
| Clover Health Investments (CLOV) | United States | $1.394B | 0.00 |
| Omnicell (OMCL) | United States | $1.346B | 23.75 |
| Evolent Health (EVH) | United States | $1.257B | 107.10 |
| Claritev (CTEV) | United States | $0.687B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.596B | 0.00 |
| Veradigm (MDRX) | United States | $0.487B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.487B | 0.00 |
| Standard BioTools (LAB) | United States | $0.475B | 0.00 |
| Talkspace (TALK) | United States | $0.452B | 135.00 |
| Outset Medical (OM) | United States | $0.347B | 0.00 |
| TruBridge (TBRG) | United States | $0.343B | 762.00 |
| Nyxoah SA (NYXH) | Belgium | $0.265B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.262B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.211B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.157B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.136B | 0.00 |
| American Well (AMWL) | United States | $0.116B | 0.00 |
| CareCloud (CCLD) | United States | $0.107B | 4.06 |
| Pulmonx (LUNG) | United States | $0.106B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.105B | 0.00 |
| 111 (YI) | China | $0.067B | 0.00 |
| HeartBeam (BEAT) | United States | $0.048B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.044B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.043B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
| Zhongchao (ZCMD) | China | $0.031B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |